Neumora Therapeutics (NMRA.US) is covered by Motorola for the first time and gives an overweight rating with a target price of $21.00.
Neumora Therapeutics(NMRA.US)获小摩首次覆盖，给予增持评级, 目标价21.00美元。
Neumora Therapeutics (NMRA.US) was covered by Komo for the first time and was given an increase in holdings rating, with a target price of $21.00.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.